FDA Issues Alert on Severe Allergic Reactions Linked to Copaxone and Glatopa, Calls for Immediate Medical Attention in New Cases
Washington, D.C. – Health experts are warning patients and healthcare providers about the rare but potentially lethal risks of anaphylaxis linked to the use of the drugs Copaxone and Glatopa, commonly prescribed for multiple sclerosis. Anaphylaxis, a severe allergic reaction, demands immediate medical intervention and manifests through symptoms such as wheezing, skin rash, vomiting, and … Read more